查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866536

疤痕治療市場－2025-2030年預測

Scar Treatment Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計疤痕治療市場將從 2025 年的 171.12 億美元成長到 2030 年的 250.96 億美元，複合年成長率為 7.96%。

疤痕治療市場是皮膚科和美容醫學領域的重要組成部分，主要針對創傷、手術、燒燙傷、挫傷及其他原因造成的疤痕，這些疤痕會影響皮膚的美觀和功能。此市場涵蓋的疤痕類型包括瘢痕疙瘩、攣縮性疤痕、增生性疤痕和萎縮性疤痕（主要與挫傷相關），治療方法包括外用產品、雷射治療、注射療法以及新興的微創治療方法。隨著人們對美觀的日益關注和創傷治療技術的進步，該市場透過線上和線下管道服務於包括醫院、診所和藥房在內的各類終端用戶。

本報告檢驗了疤痕治療市場當前的需求、供應和銷售趨勢，以及影響該市場發展的最新動態。報告全面分析了關鍵促進因素、阻礙因素和機遇，並深入探討了區域產業趨勢、政策和法規，使相關人員能夠深入了解法規結構和影響市場環境的關鍵因素。

我們的競爭情報是基於廣泛的二手資料研究，旨在識別關鍵產業參與者及其收入貢獻。資訊來源包括產業協會調查、分析師報告、投資者報告、新聞稿和學術期刊。我們採用由下而上和自上而下相結合的方法計算了疤痕治療行業及其主要細分市場的市場規模。相關數據已透過全球疤痕治療價值鏈相關人員的第一手資訊進行檢驗。我們全面的市場分析整合了多種資訊來源和專有資料集，並運用資料三角驗證法，以提供準確的市場區隔和預測。

市場洞察透過分析性敘述、圖表和圖形呈現，使讀者能夠有效率地了解全球疤痕治療市場的趨勢。 2024年全球市場規模為292.5億美元，預計2025年將達322.9億美元，2034年將達到762億美元，複合年成長率為10.05%。主要主要企業包括CCA Industries, Inc.、Cynosure, Inc.、Smith & Nephew, Inc.、Sientra, Inc.和Lumenis, Inc.。

主要亮點

由於挫傷疤痕在全球普遍存在，因此已成為主流問題，也帶動了對局部治療的需求。北美憑藉其先進的醫療基礎設施處於領先主導，而亞太地區則因人們日益增強的美學意識而成長最快。從治療類型來看，局部用藥佔主導地位，矽凝膠等創新技術進一步提升了其療效。雷射治療的高成本以及非處方藥缺乏實證醫學證據，限制了局部用藥市場的成長。

成長要素

皮膚損傷（如挫傷和燒燙傷）的日益普遍（每年影響1100萬人）推動了市場需求。社群媒體提高了人們對美的認知，並鼓勵年輕一代接受美容產品。先進雷射和外用製劑等技術創新正在改善治療效果。外科手術的增加也導致了術後疤痕管理需求的成長。

抑制因素

雷射療法等先進治療方法的高昂費用限制了其在低收入地區的普及，非處方藥的臨床證據有限削弱了消費者的信心，而熟練的皮膚科醫生短缺阻礙了專業治療方法的廣泛應用。

細分分析

依疤痕類型分類：萎縮性（挫傷）疤痕將在2024年佔據市場主導地位，市佔率達37.9%，這主要歸因於其在年輕人中的高發生率。瘢痕疙瘩和增生性疤痕的發生率也在迅速上升，這主要是由於外科手術和燒燙傷病例的增加。

依治療類型分類：由於價格實惠且使用方便，外用藥物預計在2024年將佔據60.5%的市場佔有率。雷射治療由於能夠促進膠原蛋白重塑以改善深層疤痕，預計將呈現最快的成長速度。

按最終用戶分類：擁有先進設備的醫院佔比最大，為 37.2%，而提供專業美容服務的診所也在快速成長。

按分銷管道分類：線上管道正在迅速擴張，從而增加了人們獲得非處方藥的機會。

區域分析

到2024年，北美將佔據38%的市場佔有率，這得益於其基礎設施和創新技術，例如獲得FDA批准的雷射技術。亞太地區將以12%的複合年成長率加速成長，主要受中國和印度收入成長以及創傷性損傷病例增加的推動。歐洲將受益於監管支持和人口老化，保持成長動能。

本報告為業內人士提供關於市場趨勢、監管環境和競爭動態的關鍵洞察。報告重點介紹了個人化治療和微創療法的機遇，同時也探討了成本效益的挑戰。嚴謹的調查方法結合一手和二手數據，確保了資訊的可靠性，幫助相關人員理解複雜的市場格局，並優先考慮在這一不斷發展的領域進行投資，該領域對於美容和功能性皮膚護膚至關重要。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 按疤痕類型分類的疤痕治療市場

  • 介紹
  • 瘢痕疙瘩
  • 攣縮性瘢痕
  • 增生性瘢痕
  • 挫傷疤痕
  • 燒燙傷疤痕
  • 術後瘢痕
  • 其他

第6章 依治療類型分類的疤痕治療市場

  • 介紹
  • 矽膠製品
    • 床單
    • 凝膠
  • 外用乳霜和軟膏
  • 外科手術和介入治療
    • 雷射療法
    • 微針療法
    • 冷凍療法
    • 化學換膚
  • 注射
    • 類固醇注射
    • 填料

7. 按最終用戶分類的疤痕治療市場

  • 介紹
  • 醫院和診所
  • 零售
  • 醫療水療中心

8. 按分銷管道分類的疤痕治療市場

  • 介紹
  • 線上
  • 離線
    • 醫院藥房
    • 零售店

9. 按地區分類的疤痕治療市場

  • 介紹
  • 北美洲
    • 按疤痕類型
    • 按治療類型
    • 最終用戶
    • 透過分銷管道
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按疤痕類型
    • 按治療類型
    • 最終用戶
    • 透過分銷管道
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按疤痕類型
    • 按治療類型
    • 最終用戶
    • 透過分銷管道
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 義大利
      • 其他
  • 中東和非洲
    • 按疤痕類型
    • 按治療類型
    • 最終用戶
    • 透過分銷管道
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 按疤痕類型
    • 按治療類型
    • 最終用戶
    • 透過分銷管道
    • 按國家/地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 台灣
      • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第11章：公司簡介

  • CCA Industries, Inc.
  • Cynosure Lutronic
  • Smith & Nephew plc
  • Lumenis
  • Merz Pharma
  • Sonoma Pharmaceuticals, Inc.
  • NewMedical Technology, Inc.
  • Bausch Health Companies Inc.
  • BirchBioMed
  • Perrigo Company plc
  • Stratpharma
  • Molnlycke Health Care AB
  • Alliance Pharma

第12章調查方法

簡介目錄
Product Code: KSI061611964

The Scar Treatment Market will surge from USD 17.112 billion in 2025 to USD 25.096 billion by 2030, fueled by a 7.96% compound annual growth rate (CAGR).

The scar treatment market, a vital subset of dermatology and aesthetics, addresses scarring from injuries, surgeries, burns, and conditions like acne, impacting both cosmetic and functional aspects of skin health. This sector encompasses topical products, laser therapies, injectables, and emerging minimally invasive options, catering to scar types including keloids, contractures, hypertrophic, and atrophic (predominantly acne-related). With rising aesthetic awareness and advancements in wound healing, the market supports diverse end-users-hospitals, clinics, pharmacies-via online and offline channels.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the scar treatment market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and critical factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall scar treatment sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global scar treatment value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global scar treatment market dynamics. The global market, valued at USD 29.25 billion in 2024, is projected to reach USD 32.29 billion in 2025 and USD 76.20 billion by 2034, growing at a CAGR of 10.05%. Key players profiled include CCA Industries, Inc., Cynosure, Inc., Smith & Nephew plc, Sientra, Inc., and Lumenis, among others.

Key Highlights

Acne scars dominate due to high global prevalence, driving demand for topical treatments. North America leads with advanced healthcare infrastructure; Asia Pacific grows fastest due to rising aesthetic awareness. Topical products lead treatment types; innovations like silicone gels enhance efficacy. High costs of laser therapies and limited OTC evidence restrain growth.

Growth Drivers

Increasing prevalence of skin conditions, including acne and burns affecting 11 million annually, propels demand. Growing aesthetic awareness, amplified by social media, boosts adoption among younger demographics. Technological innovations, such as advanced lasers and topical formulations, improve outcomes. Rising surgical procedures heighten needs for post-operative scar management.

Restraints

High costs of advanced treatments like lasers limit accessibility in low-income regions. Limited clinical evidence for OTC products erodes consumer confidence. Shortage of skilled dermatologists hampers adoption of specialized therapies.

Segmentation Analysis

By Scar Type: Atrophic (acne) scars lead with 37.9% share in 2024, driven by high incidence among youth. Keloids and hypertrophic scars grow rapidly due to surgical and burn cases.

By Treatment Type: Topicals hold 60.5% share in 2024, favored for affordability and ease. Lasers exhibit fastest growth via collagen remodeling for deeper scars.

By End-User: Hospitals dominate at 37.2%, offering advanced infrastructure. Clinics surge with specialized aesthetic services.

By Distribution Channel: Online channels expand rapidly, enhancing access for OTC products.

Regional Analysis

North America commands 38% share in 2024, bolstered by infrastructure and innovations like FDA-cleared lasers. Asia Pacific, at 12% CAGR, accelerates via rising incomes and trauma incidents in China and India. Europe sustains growth through regulatory support and aging populations.

Key Developments

In 2024, Cynosure's PicoSure Pro laser gained FDA clearance for acne scars, enhancing precision. Singapore's A*STAR launched microneedle patches for targeted delivery. Nuance Medical acquired Biocorneum in May 2024, expanding silicone gel offerings.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in personalized therapies and minimally invasive options while addressing cost and efficacy challenges. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate complexities and prioritize investments in this evolving sector essential to aesthetic and functional skin care.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Scar Type

  • Keloid Scars
  • Contracture Scars
  • Hypertrophic Scars
  • Acne Scars
  • Burn Scars
  • Post-Surgical Scars
  • Others

By Treatment Type

  • Silicone-based Products
  • Sheets
  • Gels
  • Topicals Creams & Ointments
  • Surgical & Procedural Treatments
  • Laser Therapy
  • Microneedling
  • Cryotherapy
  • Chemical Peels
  • Injectables
  • Steroid Injections
  • Fillers

By End-User

  • Hospitals & Clinics
  • Retail
  • Medical Spas

By Distribution Channel

  • Online
  • Offline
  • Hospital Pharmacies
  • Retail

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SCAR TREATMENT MARKET BY SCAR TYPE

  • 5.1. Introduction
  • 5.2. Keloid Scars
  • 5.3. Contracture Scars
  • 5.4. Hypertrophic Scars
  • 5.5. Acne Scars
  • 5.6. Burn Scars
  • 5.7. Post-Surgical Scars
  • 5.8. Others

6. SCAR TREATMENT MARKET BY TREATMENT TYPE

  • 6.1. Introduction
  • 6.2. Silicone-based Products
    • 6.2.1. Sheets
    • 6.2.2. Gels
  • 6.3. Topicals Creams & Ointments
  • 6.4. Surgical & Procedural Treatments
    • 6.4.1. Laser Therapy
    • 6.4.2. Microneedling
    • 6.4.3. Cryotherapy
    • 6.4.4. Chemical Peels
  • 6.5. Injectables
    • 6.5.1. Steroid Injections
    • 6.5.2. Fillers

7. SCAR TREATMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Retail
  • 7.4. Medical Spas

8. SCAR TREATMENT MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail

9. SCAR TREATMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Scar Type
    • 9.2.2. By Treatment Type
    • 9.2.3. By End-User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. United States
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Scar Type
    • 9.3.2. By Treatment Type
    • 9.3.3. By End-User
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Scar Type
    • 9.4.2. By Treatment Type
    • 9.4.3. By End-User
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Italy
      • 9.4.5.5. Others
  • 9.5. Middle East & Africa
    • 9.5.1. By Scar Type
    • 9.5.2. By Treatment Type
    • 9.5.3. By End-User
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Scar Type
    • 9.6.2. By Treatment Type
    • 9.6.3. By End-User
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. Japan
      • 9.6.5.2. China
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. CCA Industries, Inc.
  • 11.2. Cynosure Lutronic
  • 11.3. Smith & Nephew plc
  • 11.4. Lumenis
  • 11.5. Merz Pharma
  • 11.6. Sonoma Pharmaceuticals, Inc.
  • 11.7. NewMedical Technology, Inc.
  • 11.8. Bausch Health Companies Inc.
  • 11.9. BirchBioMed
  • 11.10. Perrigo Company plc
  • 11.11. Stratpharma
  • 11.12. Molnlycke Health Care AB
  • 11.13. Alliance Pharma

12. RESEARCH METHODOLOGY